Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-24,245
Closed -$1.01M 388
2021
Q1
$1.01M Buy
24,245
+45
+0.2% +$2.05K ﹤0.01% 301
2020
Q4
$1.03M Sell
24,200
-4,734
-16% -$170K ﹤0.01% 292
2020
Q3
$760K Sell
28,934
-373
-1% -$10.4K ﹤0.01% 255
2020
Q2
$786K Sell
29,307
-8,000
-21% -$180K ﹤0.01% 250
2020
Q1
$671K Sell
37,307
-16,189
-30% -$307K ﹤0.01% 243
2019
Q4
$948K Buy
53,496
+3,292
+7% +$57K ﹤0.01% 257
2019
Q3
$779K Hold
50,204
﹤0.01% 261
2019
Q2
$863K Sell
50,204
-3,880
-7% -$62.6K ﹤0.01% 243
2019
Q1
$871K Sell
54,084
-5,916
-10% -$95.9K 0.01% 270
2018
Q4
$878K Sell
60,000
-1,000
-2% -$16K 0.01% 270
2018
Q3
$1.11M Sell
61,000
-3,500
-5% -$61.3K 0.01% 273
2018
Q2
$1.09M Sell
64,500
-10,000
-13% -$189K 0.01% 271
2018
Q1
$1.46M Buy
+74,500
New +$1.44M 0.01% 245

Other funds holding HALO

TIAA FSB's HALO Position: Q2 2021 in Review

TIAA FSB sold out of Halozyme (HALO) in Q2 2021, closing a stake of 24,245 shares — an estimated $1.01M sold.

TIAA FSB first reported a position in HALO in Q1 2018 and held it in 13 quarters. The position peaked at $1.46M in Q1 2018. 313 funds tracked by Wall St. Rank hold HALO as of Q2 2021.

  • TIAA FSB reported no remaining Halozyme position as of Q2 2021 after selling out during the quarter.
  • TIAA FSB sold 24,245 Halozyme shares in Q2 2021, an estimated $1.01M.
  • TIAA FSB first reported a position in Halozyme in Q1 2018 and held it in 13 quarters.
  • TIAA FSB's Halozyme position peaked at $1.46M in Q1 2018.
  • 313 funds tracked by Wall St. Rank held Halozyme as of Q2 2021.

Based on TIAA FSB's 13F filing for Q2 2021, filed 21 Jul 2021.